ARA-290 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of ARA-290 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF-ARA10-B241

Key analytical results include:

• Assay Content: 9.36 mg
• Identification – Retention Time: 0.993
• Identification – Spectrum: 994
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: 0.020 EU per mg
• Total Aerobic Microbial Count: within acceptable range
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. :contentReference[oaicite:0]{index=0}

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

ARA-290 is a synthetic peptide studied in controlled laboratory environments focused on peptide-mediated signalling pathways and molecular regulatory systems.

The compound is commonly investigated in biochemical research for its interaction with peptide signalling mechanisms and receptor-mediated processes.

This preparation contains 10 mg of lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows precise reconstitution for controlled in vitro experimentation.

Due to its defined molecular structure and analytical profile, ARA-290 is frequently referenced in experimental peptide research models.

Compound Overview

ARA-290 is a synthetic peptide studied in biochemical research for its interaction with signalling pathways and regulatory systems.

Within experimental models, it is commonly investigated for peptide-mediated signalling dynamics and molecular interaction mechanisms.

Because of its defined molecular profile, the compound is frequently used in laboratory studies examining peptide signalling and regulatory processes.

Historical Background and Scientific Context

Scientific interest in synthetic peptides has expanded significantly with advances in molecular biology and biochemical research.

Peptides such as ARA-290 have been developed to explore signalling pathways and receptor interactions in controlled laboratory environments.

This has enabled deeper investigation into molecular mechanisms and peptide-mediated biological processes.

Mechanistic Focus in Research

Within experimental laboratory settings, ARA-290 is commonly studied in relation to peptide-mediated signalling pathways.

Research investigations commonly explore the compound in experimental models examining:

• Peptide signalling pathways
• Receptor interaction dynamics
• Regulatory network interactions
• Intracellular signalling mechanisms
• Comparative peptide research
• Molecular pathway analysis
• Receptor interaction modelling

These experimental models allow scientists to investigate molecular mechanisms involved in peptide-mediated signalling processes.

Research Applications

In controlled research environments, ARA-290 may be utilised in experimental models designed to explore peptide signalling systems and molecular interactions.

Examples of research applications include:

• Peptide signalling pathway investigation
• Receptor interaction research
• Intracellular signalling modelling
• Comparative peptide studies
• Molecular pathway analysis
• Controlled in vitro research
• Laboratory signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Independently analysed by Liquilabs s.r.o. Czechia
• Greater than 99.8 % purity confirmed by COA
• Assay content verified at 9.36 mg
• Endotoxin level measured at 0.020 EU/mg
• No detectable heavy metals or microbial contamination
• High-purity peptide for controlled laboratory research
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.